基因多态和糖尿病神经病变:从范围审查和科学度分析的见解
Rafaela Cirillo de Melo1, Paula Rothbarth Silva2, Nathalia Marçallo Peixoto Souza2
1Undergraduation in Pharmacy, Federal University of Paraná (UFPR), Curitiba 80210-170, PR, Brazil.
Diseases (Basel, Switzerland)
|September 26, 2025
概括
ангиотензин转化酶 (ACE) 基因的遗传变异,特别是 I/D 多态,可能会影响糖尿病神经病变 (DN) 的易感性. 然而,结果因种族和研究设计而异,需要进一步研究.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病神经病变 (DN) 是糖尿病 (DM) 的常见并发症,影响多种神经类型.
- 遗传因素,包括 ангиотензин转化酶 (ACE) 基因多态性,正在研究它们在DN易感性中的作用.
研究的目的:
- 综合关于ACE基因多态性及其与DNA的关联的证据.
- 进行相关研究的范围审查和科学度分析.
主要方法:
- 在PubMed,Scopus和Web of Science的综合文献搜索.
- 包括关于DN和ACE基因定型的观察性研究.
- 在RStudio.com中使用Bibliometrix进行Scientometric测绘.
主要成果:
- 11项研究符合纳入标准,重点关注外围和心脏自主神经病变.
- 在超过一半的研究中,ACE I/D多态,特别是D等位基因和DD基因型,与增加DN敏感性有关.
- 在一些研究中,II基因型表现出保护作用,在种族和研究设计中发现了差异.
结论:
- ACE I/D 多态可能调节DN易受性,但种族间的变异性和方法上的差异限制了最终的结论.
- 需要进一步的标准化研究来确认ACE基因多态性作为DN的预测生物标志物.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
936
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
936
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
Hypertension II: Pathophysiology
795
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795


